Viking Therapeutics
VKTX
$76.97
Share price
1.60%
Change (1 day)
236.70%
Change (1 year)
Categories
Viking Therapeutics (VKTX) - Total assets
Total assets on the balance sheet as of March 2024 : $0.96 B
According to Viking Therapeutics 's latest financial reports the company's total assets are $0.96 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Viking Therapeutics - Total assets on balance sheet (from 2014 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.36 B | 118.65% |
| 2022-12-31 | $0.16 B | -20% |
| 2021-12-31 | $0.21 B | -17.87% |
| 2020-12-31 | $0.25 B | -9.76% |
| 2019-12-31 | $0.28 B | -5.97% |
| 2018-12-31 | $0.30 B | 1266.63% |
| 2017-12-31 | $22.12 M | 52.18% |
| 2016-12-31 | $14.53 M | -5.85% |
| 2015-12-31 | $15.43 M | 407.34% |
| 2014-12-31 | $3.04 M | 1586.94% |
| 2013-12-31 | $0.18 M | |
| 2012-12-31 | $N/A |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | $1.49 B | 54.11% | 🇺🇸 USA |
 Repligen
RGEN | $2.82 B | 191.92% | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |